Breast Thermogram Risk Assessment

A risk assessment for each breast is provided by the evaluating doctor on a scale of 1 to 5, with 1 being the lowest risk and 5 being the highest risk.

Rating Risk Explanation

TH1

Lowest Risk

Bilaterally symmetrical, nonvascular (non-suspicious, normal study). These ratings suggest low risk of current or future breast disease. These ratings do not guarantee that the breasts are disease-free and should not delay any other breast examination recommended by your doctor.

TH2

Low Risk

Bilaterally symmetrical, vascular (non-suspicious, normal study). These ratings suggest low risk of current or future breast disease. These ratings do not guarantee that the breasts are disease-free and should not delay any other breast examination recommended by your doctor. The increase in risk between TH1 and TH2 is minimal.

TH3

Medium Risk

Equivocal. (low index of suspicion). This rating suggests signs of physiologic stress and/or inflammation. It suggests that a patient has a mid-level risk that disease is currently present or may develop in the future. Serial imaging with thermography is recommended in order to determine if the patient’s findings are normal. Other diagnostic tests may be needed if not already done, such as manual breast exam, mammography, ultrasound, and/or MRI.

TH4

High Risk

Abnormal (moderate index of suspicion). This rating suggests substantial signs of physiologic stress and/or inflammation. It suggests that a patient is at high risk that disease is currently present or may develop in the future. This rating does not guarantee that disease is present, and needs to be evaluated by other imaging to determine its significance. Additional testing such as MRI, mammography, ultrasound, tumor markers, manual breast exam or other diagnostic tests should be performed.

TH5

Highest Risk

Highly abnormal (high index of suspicion). This rating a high risk that disease is currently present or will develop in the future. This rating does not guarantee that disease is present, and needs to be evaluated by other imaging to determine its significance. Additional testing such as MRI, mammography, ultrasound, tumor markers, manual breast exam or other diagnostic tests should be performed.